Health Care International - FluoroPharma Announces Positive Phase I Safety Results For BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer For Positron Emission Tomography (PET)
FluoroPharma Inc., a company developing breakthrough molecular imaging agents for the Positron Emission Tomography (PET) market, announced positive Phase I results for BFPET, its novel Fluorine-18 labeled tracer for myocardial perfusion imagin
Comments